At NYU Langone’s Ventricular Assist Device (VAD) Program, we offer leading edge, lifesaving mechanical circulatory support for two major conditions: acute cardiogenic shock, in which the heart muscle abruptly stops working, and chronic advanced heart failure, in which the heart muscle is permanently weakened and doesn’t pump blood and oxygen throughout the body efficiently.
After someone experiences acute cardiogenic shock, a temporary ventricular assist device can be implanted to help circulate blood throughout the body until the heart recovers. In chronic heart failure, a left ventricular assist device (LVAD) can help extend—and improve—the lives of certain patients, whether you are awaiting heart transplant or you are not a candidate for one. This treatment has been shown to increase patient survival, sometimes by more than five years.
Through the VAD program, NYU Langone offers all LVAD devices approved by the U.S. Food and Drug Administration for treating advanced heart failure. What’s more, our VAD program has earned advanced certification from The Joint Commission, the nation’s oldest and largest standards-setting and accrediting body in healthcare.
Our team of heart failure cardiologists and cardiac surgeons, nurse practitioners, social workers, and other specialists work together to provide personalized care before, during, and after surgery to implant an LVAD. Our experts are available 24 hours a day, seven days a week, through our dedicated hotline, and we monitor your progress daily to ensure that you are safely taking medications and making lifestyle changes designed to improve your overall health.